Diabetics | Controls | P-value | |
---|---|---|---|
Sex (male/female) | 46/44 | 46/44 | - |
Age (years) | 59 ± 10 | 59 ± 10 | - |
Diabetes duration (years) (median(IQR)) | 1.9(0.8;3.2) | - | - |
HbA1c (%) (median(IQR)) | 6.5 (6.2;6.8) | 5.7 (5.5;5.8) | <0.001 |
Body Mass Index (BMI)(kg/m2) | 30 ± 5 | 26 ± 4 | <0.001 |
Smoking (present/previous/never) | 19/33/38 | 19/30/41 | 0.88 |
Statins (yes/no) | 70/20 | 16/74 | <0.001 |
Antihypertensive treatment (yes/no) | 57/33 | 25/65 | <0.001 |
History of cardiovascular disease (yes/no) | 17/73 | 10/80 | <0.001 |
Total-cholesterol (mmol/l) | 4.3 ± 0.8 | 5.7 ± 1.0 | <0.001 |
LDL-cholesterol (mmol/l) | 2.2 ± 0.7 | 3.4 ± 1.0 | <0.001 |
HDL-cholesterol (mmol/l) | 1.4 ± 0.3 | 1.7 ± 0.6 | <0.001 |
Triglycerides (mmol/l) (median(IQR)) | 1.4 (1.1;2.0) | 1.2 (0.9;1.6) | <0.05 |
Office systolic BP (mmHg) | 126 ± 12 | 132 ± 14 | <0.01 |
Office diastolic BP (mmHg) | 79 ± 8 | 84 ± 10 | <0.001 |
Office pulse pressure (mmHg) | 47 ± 10 | 48 ± 10 | 0.73 |
Office mean arterial pressure (mmHg) | 95 ± 8.3 | 100 ± 11 | <0.01 |
Office heart rate (beats/min) | 66 ± 10 | 62 ± 10 | <0.01 |
24-h ABPM systolic BP (mmHg) | 126 ± 11 | 125 ± 12 | 0.40 |
24-h ABPM diastolic BP (mmHg) | 75 ± 8 | 76 ± 8 | 0.26 |
24-h ABPM pulse pressure (mmHg) | 52 ± 9 | 49 ± 9 | <0.05 |
24-h ABPM mean arterial pressure (mmHg) | 92 ± 8 | 93 ± 8 | 0.86 |
24-h heart rate (beats/min) | 74 ± 10 | 68 ± 9 | <0.01 |
Creatinine (μmol/liter) | 72 ± 14 | 76 ± 14 | <0.01 |
Estimated GFR (mL/min/1.73 m2) (median(IQR)) | 75 (66;87) | 70(63;78) | <0.01 |
Urine albumine/creatinine ratio (mg/mmol) (median(IQR)) | 0.40 (0.28;0.98) | 0.25 (0.17;0.40) | <0.001 |
Carotid-femoral pulse wave velocity (m/s) | 9.3 ± 2 | 8.0 ± 1.6 | <0.001 |